02.12.2018 Diabetes treating ‘SGLT2 inhibitors’ named among top advances for preventing heart disease SGLT2 inhibitors, a promising class of diabetes drugs, were shown to significantly lower the rates of heart failure and death in the large CVD-REAL study. Read more
